Literature DB >> 32681206

Progressive B Cell Loss in Revertant X-SCID.

Connie H Lin1, Hye Sun Kuehn2, Timothy J Thauland1, Christine M Lee3, Suk See De Ravin4, Harry L Malech4, Timothy J Keyes5, Astraea Jager5, Kara L Davis5, Maria I Garcia-Lloret1, Sergio D Rosenzweig2, Manish J Butte6.   

Abstract

We report the case of a patient with X-linked severe combined immunodeficiency (X-SCID) who survived for over 20 years without hematopoietic stem cell transplantation (HSCT) because of a somatic reversion mutation. An important feature of this rare case included the strategy to validate the pathogenicity of a variant of the IL2RG gene when the T and B cell lineages comprised only revertant cells. We studied the X-inactivation of sorted T cells from the mother to show that the pathogenic variant was indeed the cause of his SCID. One interesting feature was a progressive loss of B cells over 20 years. CyTOF (cytometry time of flight) analysis of bone marrow offered a potential explanation of the B cell failure, with expansions of progenitor populations that suggest a developmental block. Another interesting feature was that the patient bore extensive granulomatous disease and skin cancers that contained T cells, despite severe T cell lymphopenia in the blood. Finally, the patient had a few hundred T cells on presentation but his TCRs comprised a very limited repertoire, supporting the important conclusion that repertoire size trumps numbers of T cells.

Entities:  

Keywords:  B cells; IL2RG; SCID; T cells; somatic reversion

Year:  2020        PMID: 32681206      PMCID: PMC7508923          DOI: 10.1007/s10875-020-00825-3

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  19 in total

1.  Murine and human IL-7 activate STAT5 and induce proliferation of normal human pro-B cells.

Authors:  Sonja E Johnson; Nisha Shah; Angela Panoskaltsis-Mortari; Tucker W LeBien
Journal:  J Immunol       Date:  2005-12-01       Impact factor: 5.422

2.  Single-cell trajectory detection uncovers progression and regulatory coordination in human B cell development.

Authors:  Sean C Bendall; Kara L Davis; El-Ad David Amir; Michelle D Tadmor; Erin F Simonds; Tiffany J Chen; Daniel K Shenfeld; Garry P Nolan; Dana Pe'er
Journal:  Cell       Date:  2014-04-24       Impact factor: 41.582

3.  Three new loci for determining x chromosome inactivation patterns.

Authors:  Birgitte Bertelsen; Zeynep Tümer; Kirstine Ravn
Journal:  J Mol Diagn       Date:  2011-07-02       Impact factor: 5.568

4.  IL-21 is the primary common γ chain-binding cytokine required for human B-cell differentiation in vivo.

Authors:  Mike Recher; Lucinda J Berglund; Danielle T Avery; Morton J Cowan; Andrew R Gennery; Joanne Smart; Jane Peake; Melanie Wong; Sung-Yun Pai; Sachin Baxi; Jolan E Walter; Umaimainthan Palendira; Gillian A Tangye; Michael Rice; Shannon Brothers; Waleed Al-Herz; Hans Oettgen; Hermann Eibel; Jennifer M Puck; Federica Cattaneo; John B Ziegler; Silvia Giliani; Stuart G Tangye; Luigi D Notarangelo
Journal:  Blood       Date:  2011-10-28       Impact factor: 22.113

5.  Single-cell developmental classification of B cell precursor acute lymphoblastic leukemia at diagnosis reveals predictors of relapse.

Authors:  Zinaida Good; Jolanda Sarno; Astraea Jager; Nikolay Samusik; Nima Aghaeepour; Erin F Simonds; Leah White; Norman J Lacayo; Wendy J Fantl; Grazia Fazio; Giuseppe Gaipa; Andrea Biondi; Robert Tibshirani; Sean C Bendall; Garry P Nolan; Kara L Davis
Journal:  Nat Med       Date:  2018-03-05       Impact factor: 53.440

6.  Single-cell mass cytometry of differential immune and drug responses across a human hematopoietic continuum.

Authors:  Sean C Bendall; Erin F Simonds; Peng Qiu; El-ad D Amir; Peter O Krutzik; Rachel Finck; Robert V Bruggner; Rachel Melamed; Angelica Trejo; Olga I Ornatsky; Robert S Balderas; Sylvia K Plevritis; Karen Sachs; Dana Pe'er; Scott D Tanner; Garry P Nolan
Journal:  Science       Date:  2011-05-06       Impact factor: 47.728

7.  A critical role for IL-21 in regulating immunoglobulin production.

Authors:  Katsutoshi Ozaki; Rosanne Spolski; Carl G Feng; Chen-Feng Qi; Jun Cheng; Alan Sher; Herbert C Morse; Chengyu Liu; Pamela L Schwartzberg; Warren J Leonard
Journal:  Science       Date:  2002-11-22       Impact factor: 47.728

Review 8.  Somatic mosaicism in primary immune deficiencies.

Authors:  Taizo Wada; Fabio Candotti
Journal:  Curr Opin Allergy Clin Immunol       Date:  2008-12

9.  Immune reconstitution and survival of 100 SCID patients post-hematopoietic cell transplant: a PIDTC natural history study.

Authors:  Jennifer Heimall; Brent R Logan; Morton J Cowan; Luigi D Notarangelo; Linda M Griffith; Jennifer M Puck; Donald B Kohn; Michael A Pulsipher; Suhag Parikh; Caridad Martinez; Neena Kapoor; Richard O'Reilly; Michael Boyer; Sung-Yun Pai; Frederick Goldman; Lauri Burroughs; Sharat Chandra; Morris Kletzel; Monica Thakar; James Connelly; Geoff Cuvelier; Blachy J Davila Saldana; Evan Shereck; Alan Knutsen; Kathleen E Sullivan; Kenneth DeSantes; Alfred Gillio; Elie Haddad; Aleksandra Petrovic; Troy Quigg; Angela R Smith; Elizabeth Stenger; Ziyan Yin; William T Shearer; Thomas Fleisher; Rebecca H Buckley; Christopher C Dvorak
Journal:  Blood       Date:  2017-10-11       Impact factor: 22.113

10.  Intact B-Cell Signaling and Function With Host B-Cells 47 Years After Transplantation for X-SCID.

Authors:  Christin Deal; Timothy J Thauland; E Richard Stiehm; Maria I Garcia-Lloret; Manish J Butte
Journal:  Front Immunol       Date:  2020-03-20       Impact factor: 7.561

View more
  2 in total

Review 1.  Immune Reconstitution After Gene Therapy Approaches in Patients With X-Linked Severe Combined Immunodeficiency Disease.

Authors:  Elena Blanco; Natalia Izotova; Claire Booth; Adrian James Thrasher
Journal:  Front Immunol       Date:  2020-11-27       Impact factor: 7.561

2.  Somatic Reversion of a Novel IL2RG Mutation Resulting in Atypical X-Linked Combined Immunodeficiency.

Authors:  Yujuan Hou; Hans Peter Gratz; Guillermo Ureña-Bailén; Paul G Gratz; Karin Schilbach-Stückle; Tina Renno; Derya Güngör; Daniel A Mader; Elke Malenke; Justin S Antony; Rupert Handgretinger; Markus Mezger
Journal:  Genes (Basel)       Date:  2021-12-23       Impact factor: 4.096

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.